Literature DB >> 9803378

Human cardiac MR spectroscopy--clinical methods and applications.

M Beer1, D Hahn, S Neubauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9803378

Source DB:  PubMed          Journal:  MAGMA        ISSN： 0968-5243            Impact factor:   2.310


× No keyword cloud information.
  10 in total

1.  Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease.

Authors:  R G Weiss; P A Bottomley; C J Hardy; G Gerstenblith
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

Authors:  M A Conway; J Allis; R Ouwerkerk; T Niioka; B Rajagopalan; G K Radda
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

3.  Is 31P-NMR spectroscopic imaging a viable approach to assess myocardial viability?

Authors:  G M Pohost
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

4.  Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy.

Authors:  B M Pluim; J C Chin; A De Roos; J Doornbos; H M Siebelink; A Van der Laarse; H W Vliegen; R M Lamerichs; A V Bruschke; E E Van der Wall
Journal:  Eur Heart J       Date:  1996-08       Impact factor: 29.983

5.  Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.

Authors:  S Neubauer; M Horn; T Pabst; K Harre; H Strömer; G Bertsch; J Sandstede; G Ertl; D Hahn; K Kochsiek
Journal:  J Investig Med       Date:  1997-10       Impact factor: 2.895

6.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.

Authors:  T Yabe; K Mitsunami; M Okada; S Morikawa; T Inubushi; M Kinoshita
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Authors:  S Neubauer; T Krahe; R Schindler; M Horn; H Hillenbrand; C Entzeroth; H Mader; E P Kromer; G A Riegger; K Lackner
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

9.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.

Authors:  W I Jung; L Sieverding; J Breuer; T Hoess; S Widmaier; O Schmidt; M Bunse; F van Erckelens; J Apitz; O Lutz; G J Dietze
Journal:  Circulation       Date:  1998-06-30       Impact factor: 29.690

10.  Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.

Authors:  S Neubauer; M Horn; A Naumann; R Tian; K Hu; M Laser; J Friedrich; P Gaudron; K Schnackerz; J S Ingwall
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.